| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,031 | 6,136 | 7,361 | 8,520 | | Cost of Revenue | (18,066) | 2,278 | 4,331 | 4,573 | | | Gross Profit | 25,097 | 3,858 | 3,030 | 3,947 | | | Operating Expenses | | Research Development | 191 | 117 | 224 | 453 | | Selling General and Administrative | 3,609 | 4,397 | 4,804 | 4,722 | | Non Recurring | 21,859 |
-
| 7,045 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (562) | (656) | (9,043) | (1,228) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (108) | 411 | (8) | (504) | | Earnings Before Interest And Taxes | (670) | (245) | (9,051) | (1,973) | | Interest Expense | 48 | 48 | 48 | 53 | | Income Before Tax | (718) | (293) | (9,099) | (2,026) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (30) | (65) |
-
| (241) | | | | Net Income From Continuing Ops | (653) | (358) | (9,099) | (2,026) | | | Non-recurring Events | | Discontinued Operations | (489) | (40) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,237) | (398) | (9,099) | (2,026) | | Preferred Stock And Other Adjustments |
-
| 36 | (36) |
-
| | | Net Income Applicable To Common Shares | ($1,237) | ($362) | ($9,135) | ($2,026) |
|
0.51% Nasdaq 
Income Statement
